Blood sampling patterns in primary care change several years before a cancer diagnosis

Hansen PL, Hjertholm P, Vedsted P. Increased diagnostic activity in general practice during the year preceding colorectal cancer diagnosis. [cited 24-05-2023]. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ijc.29418

Christensen KG, Fenger-Grøn M, Flarup KR, Vedsted P. Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis – a population-based nationwide registry study of 127,000 incident adult cancer patients. BMC Health Serv Res. 2012 [cited 31-05-2023];12(1):224. Available from: https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-12-224 DOI: https://doi.org/10.1186/1472-6963-12-224

Hansen JW, Sandholdt H, Siersma V, et al. Anemia is present years before myelodysplastic syndrome diagnosis: results from the pre-diagnostic period. Am J Hematol. 2017 [cited 01-07-2022];92(7):E130–2. Available from: https://pubmed.ncbi.nlm.nih.gov/28383148/ DOI: https://doi.org/10.1002/ajh.24757

Andersen MA, Grand MK, Brieghel C, Siersma V, Andersen CL, Niemann CU. Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia. Commun Med. 2022 [cited 31-08-2022];2(1). Available from: https://pubmed.ncbi.nlm.nih.gov/35603299/ DOI: https://doi.org/10.1038/s43856-022-00117-4

Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488–98. https://doi.org/10.1056/NEJMoa1408617 DOI: https://doi.org/10.1056/NEJMoa1408617

Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112:S92–107. https://doi.org/10.1038/bjc.2015.48 DOI: https://doi.org/10.1038/bjc.2015.48

Enblom A, Lindskog E, Hasselbalch H, et al. High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms. Eur J Intern Med. 2015;26(5):344–7. https://doi.org/10.1016/j.ejim.2015.03.009 DOI: https://doi.org/10.1016/j.ejim.2015.03.009

Koo MM, Swann R, McPhail S, et al. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 2020 [cited 06-06-2023];21(1):73. Available from: /pmc/articles/PMC6941215/ DOI: https://doi.org/10.1016/S1470-2045(19)30595-9

Weeks LD, Niroula A, Neuberg DS, et al. Prediction of risk for myeloid malignancy in clonal hematopoiesis. Blood. 2022;140(Suppl 1):2229–31. https://doi.org/10.1182/blood-2022-158960 DOI: https://doi.org/10.1182/blood-2022-158960

Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7):42–5. https://doi.org/10.1177/1403494810393562 DOI: https://doi.org/10.1177/1403494810393562

Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7):22–5. https://doi.org/10.1177/1403494810387965 DOI: https://doi.org/10.1177/1403494810387965

Nørgaard M, Skriver M, Gregersen H, Pedersen G, Schønheyder H, Sørensen H. The data quality of haematological malignancy ICD-10 diagnoses in a population-based hospital discharge registry. Eur J Cancer Prev. 2005 [cited 28-10-2021];14(3):201–6. Available from: https://pubmed.ncbi.nlm.nih.gov/15901987/ DOI: https://doi.org/10.1097/00008469-200506000-00002

ICD-10 Version:2019. [cited 21-06-2022]. Available from: https://icd.who.int/browse10/2019/en#/

Lykkegaard Andersen C, Kriegbaum M. Copenhagen Primary Care Laboratory Database. 2022 [cited 30-08-2022]. Available from: https://publichealth.ku.dk/research/databases-for-collaboration/coplab/

Greenland S, Senn SJ, Rothman KJ, et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31(4):337–50. https://doi.org/10.1007/s10654-016-0149-3 DOI: https://doi.org/10.1007/s10654-016-0149-3

Ludwig DA. Use and misuse of p-values in designed and observational studies: guide for researchers and reviewers. Aviat Sp Environ Med. 2005;76(7 I):675–80.

Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends – an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16–27. https://doi.org/10.1158/1055-9965.EPI-15-0578 DOI: https://doi.org/10.1158/1055-9965.EPI-15-0578

Pottegård A, Hallas J, Friis S, Verdoodt F, Dehlendorff C, Kjær SK. Use of prescription drugs among women diagnosed with epithelial ovarian cancer in Denmark. Acta Obstetr Gynecol Scand. 2018;97(11):1332–8. https://doi.org/10.1111/aogs.13413 DOI: https://doi.org/10.1111/aogs.13413

Boennelykke A, Jensen H, Falborg AZ, et al. Diagnostic workup of cancer in patients with new-onset anaemia: a Danish cohort study in general practice. Scand J Prim Health Care. 2021 [cited 01-07-2022];39(4):391–402. Available from: https://pubmed.ncbi.nlm.nih.gov/34463223/ DOI: https://doi.org/10.1080/02813432.2021.1970934

Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer. 2009;100(5):822–8. https://doi.org/10.1038/sj.bjc.6604935 DOI: https://doi.org/10.1038/sj.bjc.6604935

Boddu PC, Zeidan AM. Myeloid disorders after autoimmune disease. Best Pract Res Clin Haematol. 2019 [cited 18-03-2020];32(1):74–88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30927978 DOI: https://doi.org/10.1016/j.beha.2019.02.002

Espinosa G, Font J, Muñoz-Rodríguez FJ, Cervera R, Ingelmo M. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol. 2002;21(4):309–13. https://doi.org/10.1007/s100670200081 DOI: https://doi.org/10.1007/s100670200081

Buckner JC, Brown PD, O’Neill BP, Meyer FB, Wetmore CJ, Uhm JH. Central nervous system tumors. Mayo Clin Proc. 2007;82(10):1271–86. https://doi.org/10.4065/82.10.1271 DOI: https://doi.org/10.4065/82.10.1271

Nygaard C, Jensen H, Christensen J, Vedsted P. Health care use before a diagnosis of primary intracranial tumor: a Danish nationwide register study. Clin Epidemiol. 2018;10:809–29. https://doi.org/10.2147/CLEP.S147865 DOI: https://doi.org/10.2147/CLEP.S147865

Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382(10):937–50. https://doi.org/10.1056/NEJMra1810772 DOI: https://doi.org/10.1056/NEJMra1810772

Chen YK, Lin CL, Cheng FTF, Sung FC, Kao CH. Cancer risk in patients with Hashimoto’s thyroiditis: a nationwide cohort study. Br J Cancer. 2013 [cited 01-07-2022];109(9):2496. Available from: /pmc/articles/PMC3817335/ DOI: https://doi.org/10.1038/bjc.2013.597

de Paiva CR, Grønhøj C, Feldt-Rasmussen U, von Buchwald C. Association between Hashimoto’s Thyroiditis and Thyroid Cancer in 64,628 Patients. Front Oncol. 2017 [cited 01-07-2022];7(APR):53. Available from: /pmc/articles/PMC5385456/ DOI: https://doi.org/10.3389/fonc.2017.00053

Hu JX, Helleberg M, Jensen AB, Brunak S, Lundgren J. A large-cohort, longitudinal study determines precancer disease routes across different cancer types. Cancer Res. 2019;79:864–72. https://doi.org/10.1158/0008-5472.CAN-18-1677 DOI: https://doi.org/10.1158/0008-5472.CAN-18-1677

O’Sullivan DE, Sutherland RL, Town S, et al. Risk factors for early-onset colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022 [cited 06-06-2023];20(6):1229–40.e5. Available from: https://pubmed.ncbi.nlm.nih.gov/33524598/ DOI: https://doi.org/10.1016/j.cgh.2021.01.037

Almatrafi A, Thomas O, Callister M, Gabe R, Beeken RJ, Neal R. The prevalence of comorbidity in the lung cancer screening population: a systematic review and meta-analysis. J Med Screen. 2022;30(1):3–13. https://doi.org/10.1177/09691413221117685 DOI: https://doi.org/10.1177/09691413221117685

Dansk Akut Leukaemi Database & Myelodysplastisk Syndrom Database. [cited 29-11-2021]. Available from: www.leukemia.dk

Deschler B, Lübbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107(9):2099–107. https://doi.org/10.1002/cncr.22233 DOI: https://doi.org/10.1002/cncr.22233

krabek P, Turner D, Seftel M. Epidemiology of non-Hodgkin lymphoma. Transfus Apher Sci. 2013 [cited 06-06-2023];49(2):133–8. Available from: https://pubmed.ncbi.nlm.nih.gov/23958141/ DOI: https://doi.org/10.1016/j.transci.2013.07.014

Anderson LA, McMullin MF. Epidemiology of MPN: what do we know? Curr Hematol Malig Rep. 2014;9(4):340–9. https://doi.org/10.1007/s11899-014-0228-z DOI: https://doi.org/10.1007/s11899-014-0228-z

Ma X. Epidemiology of myelodysplastic syndromes. Am J Med. 2012;125(7 suppl.):S2. https://doi.org/10.1016/j.amjmed.2012.04.014 DOI: https://doi.org/10.1016/j.amjmed.2012.04.014

Alabrach Y, Mahmoud AA, Abdelhay A et al. Trends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades. Expert Rev Hematol. 2023;16(10):785–91. https://doi.org/10.1080/17474086.2023.2243385 DOI: https://doi.org/10.1080/17474086.2023.2243385